IP Library Assignment 032036/0624
Patent Assignment
Reel/Frame 032036/0624

Release of Security Interest

Recorded: 2014-01-24 Pages: 5
Assignor
Assignee
VIROPHARMA INCORPORATED
397 EAGLEVIEW BOULEVARD, EXTON, PENNSYLVANIA, 19392
Covered Properties (8)
Liquid delivery system
Application: 11/789,652 →
Publication: US 2008/0035667
Apparatus and Methods for Reducing Capsule Elongation
Patent: 8,371,092 →
Application: 12/555,602 →
Crystalline Phases of 5,6-Dichloro-2-(Isopropylamino)-(1-Bl-L-Ribofuranosyl)1H-Benzimidazole
Application: 61/407,622 →
Crystalline Phases of 5,6-Dichloro-2-(Isopropylamino)-1-Beta-L-Ribofuranosyl-1H-Benzimidazole
Application: 61/407,626 →
Maribavir Isomers, Compositions, Methods of Making and Methods of Using
Application: 61/407,637 →
Environmental Clostridial Bacteriotherapy and Related Formulations and Methods of Manufacture and Use
Application: 61/381,693 →
Oxadiazolyl-Phenoxyalkylisoxazoles, Compositions Thereof and Methods for Their Use as Anti-Picornaviral Agents
Patent: 7,429,606 →
Application: 10/487,852 →
Publication: US 2005/0043542
Oxadiazolyl-Phenoxyalkylisoxazoles, Compositions Thereof and Methods for Their Use as Anti-Picornaviral Agents
Patent: 7,585,884 →
Application: 12/183,379 →
Publication: US 2008/0293783
Related Assignments (14)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 30, 2005
From: RHODES, GERALD; NITZ, THEODORE J.
To: VIROPHARMA INCORPORATED
Reel/Frame 016454/0899 →
Assignment of Assignor's Interest May 30, 2007
From: VALENTI, MICHAEL J.
To: OSG NORWICH PHARMACEUTICALS, INC.
Reel/Frame 019356/0675 →
Corrective Assignment to Correct the Assignee's State of Incorporation and Address Previously Recorded on Reel 019356 Frame 0675. Assignor(S) Hereby Confirms the State of Incorporation Is Delaware and the Address Is 6826 State Highway 12, Norwich, New York 13815. Jun 27, 2007
From: VALENTI, MICHAEL J.
To: OSG NORWICH PHARMACEUTICALS, INC.
Reel/Frame 019487/0041 →
Assignment of Assignor's Interest Jul 17, 2007
From: OSG NORWICH PHARMACEUTICALS, INC.
To: VIROPHARMA INC.
Reel/Frame 019564/0103 →
Security Agreement Sep 12, 2011
From: VIROPHARMA INCORPORATED
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 026890/0303 →
Assignment of Assignor's Interest Jan 10, 2013
From: DODSWORTH, DAVID W.; BRADLEY, JACK
To: VIROPHARMA INCORPORATED
Reel/Frame 029604/0667 →
Assignment of Assignor's Interest Jan 10, 2013
From: NORWICH PHARMACEUTICALS, INC.
To: VIROPHARMA INCORPORATED
Reel/Frame 029604/0615 →
Assignment of Assignor's Interest Jan 10, 2013
From: BARNHART, PAUL; RUDY, JEFFERY A.; HALL, TODD M.
To: NORWICH PHARMACEUTICALS, INC.
Reel/Frame 029604/0498 →
Security Interest Mar 25, 2014
From: ALVOGEN INC.; ALMATICA PHARMA INC.
To: HSBC BANK USA, NATIONAL ASSOCIATION
Reel/Frame 032520/0278 →
Change of Name Jul 8, 2015
From: VIROPHARMA INCORPORATED
To: SHIRE VIROPHARMA INCORPORATED
Reel/Frame 036075/0970 →
Release of Security Interest Jan 29, 2016
From: HSBC BANK USA, NATIONAL ASSOCIATION
To: ALVOGEN, INC.; ALMATICA PHARMA INC.
Reel/Frame 037619/0101 →
Assignment of Assignor's Interest Sep 16, 2016
From: SHIRE VIROPHARMA INCORPORATED
To: NTCD, LLC
Reel/Frame 039766/0163 →
Assignment of Assignor's Interest May 20, 2021
From: SHIRE VIROPHARMA LLC
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 056307/0254 →
Change of Name Jun 15, 2021
From: SHIRE VIROPHARMA INCORPORATED
To: SHIRE VIROPHARMA LLC
Reel/Frame 056596/0380 →